Infant Bacterial Therapeutics AB (9IB.STU) Q1 2026 Earnings

6FebConfirmed
Q1 2026
-0.13
0.2
0.54
0.87

Details

Expected EPS
N/A
Actual EPS
-0.1309291412
Surprise EPS
-0.13
Surprise Percent
+∞%

Description

Infant Bacterial Therapeutics AB (9IB.STU) has reported earnings of -0.1309291412 per share for Q1 2026.

0 Comments

Share your thoughts